PharmaCyte Executives Meet With Translational Drug Development to Advance Pancreatic Cancer Clinical Trial
January 25, 2016 09:25 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Jan. 25, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes...
PharmaCyte Biotech Introduces Cell-in-a-Box as a Novel Treatment for Pancreatic Cancer and Potential Cure for Type 1 Diabetes
January 19, 2016 09:25 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Jan. 19, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Raises Additional $1 Million for Pancreatic Cancer Clinical Trial
January 14, 2016 09:25 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Jan. 14, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech to Attend J.P. Morgan Healthcare Conference
January 07, 2016 09:00 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Jan. 07, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Outlines 2016 Milestones as Its Pancreatic Cancer Treatment Moves Into a Clinical Trial
January 04, 2016 08:45 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Jan. 04, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech End of Year Shareholder Update on Pancreatic Cancer and Diabetes Programs
December 30, 2015 09:00 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Dec. 30, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Releases New Video Highlighting Diabetes Treatment Development Program
December 15, 2015 09:25 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Dec. 15, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Provides Update on Malignant Ascites and New Colon Cancer Studies
December 07, 2015 09:25 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Dec. 07, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Contractor Chamow & Associates to Visit Cell-in-a-Box® Encapsulation Facility in Bangkok, Thailand
December 04, 2015 09:25 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Dec. 04, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Provides Link to Orphan Drug Designation for Its Pancreatic Cancer Treatment
November 24, 2015 09:25 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Nov. 24, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...